Allen Holding Inc.
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 7, 2026), Allen Holding Inc. reported 9 stock positions worth $1.0 billion. Its top holding was Coca-Cola (KO) at 45.3% of the portfolio, followed by Palantir Technologies Class A (PLTR, 21.8%) and Berkshire Hathaway Class A (BRK.A, 21.1%). Compared with Q4 2025, it added to 1 and reduced 2. The biggest buy was Pfizer (PFE, shares +32%) and the biggest sale Palantir Technologies Class A (PLTR, shares −6%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0000919489
- Portfolio Value
- $1.0B (Q1 2026)
- SEC Filing
- 0001214659-26-005738 ↗ filed May 7, 2026
Holdings Value
Holdings 9 stocks · $1.0B
| KO The Coca-Cola Co. | 45.28% | 6,000,000 | $456.3M | No change |
| PLTR Palantir Technologies Inc. Class A | 21.77% | 1,500,000 | $219.4M | Reduce -6.3% |
| BRK.A Berkshire Hathaway Inc. Class A | 21.09% | 296 | $212.6M | Reduce -6.6% |
| PFE Pfizer Inc. | 5.57% | 2,000,000 | $56.2M | Add +31.6% |
| PPLI People Inc. filed as IAC INC | 2.39% | 601,100 | $24.1M | No change |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 1.45% | 300,000 | $14.6M | No change |
| AFRM Affirm Holdings Inc. | 1.05% | 230,000 | $10.5M | No change |
| JPM JPMorgan Chase & Co. | 0.88% | 30,000 | $8.8M | No change |
| IBRX Immunitybio Inc. | 0.52% | 687,571 | $5.3M | No change |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
| PFE Pfizer Inc. | Add +31.6% | 5.57% | +1.97 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $1.0B | KO, BRK.A, PLTR, PFE, PPLI |
| Q1 2026 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q4 2025 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q3 2025 | 9 | $1.1B | KO, PLTR, BRK.A, PFE, PPLI |
| Q2 2025 | 10 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q1 2025 | 14 | $961.1M | KO, BRK.A, PLTR, PPLI, PFE |
| Q4 2024 | 14 | $911.8M | KO, BRK.A, PLTR, PFE, PPLI |
| Q3 2024 | 14 | $927.1M | KO, BRK.A, PLTR, BAC, PPLI |
| Q2 2024 | 14 | $800.3M | KO, BRK.A, PLTR, BAC, PPLI |
| Q1 2024 | 14 | $794.6M | KO, BRK.A, PLTR, PPLI, BAC |